TY - JOUR
T1 - A New Hierarchy of Research Evidence for Tumor Pathology
T2 - A Delphi Study to Define Levels of Evidence in Tumor Pathology
AU - Colling, Richard
AU - Indave, Iciar
AU - del Aguila, Javier
AU - Jimenez, Ramon Cierco
AU - Campbell, Fiona
AU - Chechlińska, Magdalena
AU - Kowalewska, Magdalena
AU - Holdenrieder, Stefan
AU - Trulson, Inga
AU - Worf, Karolina
AU - Pollán, Marina
AU - Plans-Beriso, Elena
AU - Pérez-Gómez, Beatriz
AU - Craciun, Oana
AU - García-Ovejero, Ester
AU - Michałek, Irmina Maria
AU - Maslova, Kateryna
AU - Rymkiewicz, Grzegorz
AU - Didkowska, Joanna
AU - Tan, Puay Hoon
AU - Md Nasir, Nur Diyana
AU - Myles, Nickolas
AU - Goldman-Lévy, Gabrielle
AU - Lokuhetty, Dilani
AU - Cree, Ian A.
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2024/1
Y1 - 2024/1
N2 - The hierarchy of evidence is a fundamental concept in evidence-based medicine, but existing models can be challenging to apply in laboratory-based health care disciplines, such as pathology, where the types of evidence and contexts are significantly different from interventional medicine. This project aimed to define a comprehensive and complementary framework of new levels of evidence for evaluating research in tumor pathology—introducing a novel Hierarchy of Research Evidence for Tumor Pathology collaboratively designed by pathologists with help from epidemiologists, public health professionals, oncologists, and scientists, specifically tailored for use by pathologists—and to aid in the production of the World Health Organization Classification of Tumors (WCT) evidence gap maps. To achieve this, we adopted a modified Delphi approach, encompassing iterative online surveys, expert oversight, and external peer review, to establish the criteria for evidence in tumor pathology, determine the optimal structure for the new hierarchy, and ascertain the levels of confidence for each type of evidence. Over a span of 4 months and 3 survey rounds, we collected 1104 survey responses, culminating in a 3-day hybrid meeting in 2023, where a new hierarchy was unanimously agreed upon. The hierarchy is organized into 5 research theme groupings closely aligned with the subheadings of the WCT, and it consists of 5 levels of evidence—level P1 representing evidence types that merit the greatest level of confidence and level P5 reflecting the greatest risk of bias. For the first time, an international collaboration of pathology experts, supported by the International Agency for Research on Cancer, has successfully united to establish a standardized approach for evaluating evidence in tumor pathology. We intend to implement this novel Hierarchy of Research Evidence for Tumor Pathology to map the available evidence, thereby enriching and informing the WCT effectively.
AB - The hierarchy of evidence is a fundamental concept in evidence-based medicine, but existing models can be challenging to apply in laboratory-based health care disciplines, such as pathology, where the types of evidence and contexts are significantly different from interventional medicine. This project aimed to define a comprehensive and complementary framework of new levels of evidence for evaluating research in tumor pathology—introducing a novel Hierarchy of Research Evidence for Tumor Pathology collaboratively designed by pathologists with help from epidemiologists, public health professionals, oncologists, and scientists, specifically tailored for use by pathologists—and to aid in the production of the World Health Organization Classification of Tumors (WCT) evidence gap maps. To achieve this, we adopted a modified Delphi approach, encompassing iterative online surveys, expert oversight, and external peer review, to establish the criteria for evidence in tumor pathology, determine the optimal structure for the new hierarchy, and ascertain the levels of confidence for each type of evidence. Over a span of 4 months and 3 survey rounds, we collected 1104 survey responses, culminating in a 3-day hybrid meeting in 2023, where a new hierarchy was unanimously agreed upon. The hierarchy is organized into 5 research theme groupings closely aligned with the subheadings of the WCT, and it consists of 5 levels of evidence—level P1 representing evidence types that merit the greatest level of confidence and level P5 reflecting the greatest risk of bias. For the first time, an international collaboration of pathology experts, supported by the International Agency for Research on Cancer, has successfully united to establish a standardized approach for evaluating evidence in tumor pathology. We intend to implement this novel Hierarchy of Research Evidence for Tumor Pathology to map the available evidence, thereby enriching and informing the WCT effectively.
KW - classification
KW - evidence based
KW - hierarchy
KW - histopathology
KW - pathology
KW - tumor
UR - http://www.scopus.com/inward/record.url?scp=85182954606&partnerID=8YFLogxK
U2 - 10.1016/j.modpat.2023.100357
DO - 10.1016/j.modpat.2023.100357
M3 - Article
C2 - 37866639
AN - SCOPUS:85182954606
SN - 0893-3952
VL - 37
JO - Modern Pathology
JF - Modern Pathology
IS - 1
M1 - 100357
ER -